Jinping Huang
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Comparative safety and efficacy of BIC/FTC/TAF versus DTG+3TC in antiretroviral treatment-naive patients with HIV as first-line regimens: A real-world cohort study.
Journal: Bioscience trends
Published: April 26, 2026
Accumulation of metabolic multimorbidity and its association with mortality: results from a prospective cohort study among people with HIV in China, 2010-2024.
Journal: The Lancet regional health. Western Pacific
Published: January 15, 2026
Incidence, recurrence, and determinants of sexually transmitted infections among people with HIV: a multicenter cohort study in China, 2010-2024, with implications for integrated HIV-STI prevention across the Western Pacific.
Journal: The Lancet regional health. Western Pacific
Published: November 02, 2025
Single-cell profiling reveals IFI44L as a central regulator of immune dysregulation in high HIV viral load.
Journal: Medical microbiology and immunology
Published: April 27, 2025
The Prevalence of Pretreatment Drug Resistance and Transmission Networks Among Newly Diagnosed HIV-1-Infected Individuals in Nanning, Guangxi, China.
Journal: Pathogens (Basel, Switzerland)
Published: February 25, 2025
Exploring ENPP5 as a diagnostic biomarker for sepsis: a comprehensive bioinformatics analysis.
Journal: BMC infectious diseases
Published: November 27, 2024
Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study.
Journal: Emerging microbes & infections
Published: December 19, 2019
An optimal BMI range associated with a lower risk of mortality among HIV-infected adults initiating antiretroviral therapy in Guangxi, China.
Journal: Scientific reports
Published: June 20, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026